Literature DB >> 9627277

Prevalence and impact of chronic joint symptoms--seven states, 1996.

.   

Abstract

Arthritis and other rheumatic conditions are the leading cause of disability the United States, affecting 42.7 million persons and costing 65 billion dollars in 1992. These numbers will increase by 2020 as the population ages. Few surveys exist to directly determine the prevalence and impact of arthritis at the state level. To address this gap, in 1995 state health departments and CDC developed a standardized, optional arthritis module for the Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes results of the analyses of 1996 data in seven states. The findings indicate that the prevalence and impact of "chronic joint symptoms"-- a proposed indicator for true arthritis and other rheumatic conditions -- is high and variable among states and that a large proportion of persons with arthritis diagnosed by a doctor do not know the type of arthritis they have.

Entities:  

Mesh:

Year:  1998        PMID: 9627277

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

Review 1.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

Review 2.  Prolotherapy in primary care practice.

Authors:  David Rabago; Andrew Slattengren; Aleksandra Zgierska
Journal:  Prim Care       Date:  2010-03       Impact factor: 2.907

3.  Knee Pain and a Prior Injury Are Associated with Increased Risk of a New Knee Injury: Data from the Osteoarthritis Initiative.

Authors:  Jeffrey B Driban; Grace H Lo; Charles B Eaton; Lori Lyn Price; Bing Lu; Timothy E McAlindon
Journal:  J Rheumatol       Date:  2015-06-01       Impact factor: 4.666

4.  Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects.

Authors:  David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

Review 5.  Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review.

Authors:  David Rabago; Bobby Nourani
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

6.  The prevalence of arthritis and activity limitation and their predictors in Missouri.

Authors:  Joseph A Vradenburg; Eduardo J Simoes; Jeannette Jackson-Thompson; Theophile Murayi
Journal:  J Community Health       Date:  2002-04

7.  Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.

Authors:  David J Hunter; Marilyn C Pike; Beth L Jonas; Eugene Kissin; Julie Krop; Tim McAlindon
Journal:  BMC Musculoskelet Disord       Date:  2010-10-10       Impact factor: 2.362

8.  Symptoms of the knee and hip in individuals with and without limb length inequality.

Authors:  Y M Golightly; K D Allen; C G Helmick; J B Renner; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2008-11-19       Impact factor: 6.576

Review 9.  The individual and socioeconomic impact of osteoarthritis.

Authors:  David J Hunter; Deborah Schofield; Emily Callander
Journal:  Nat Rev Rheumatol       Date:  2014-03-25       Impact factor: 20.543

10.  Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review.

Authors:  Salahuddin Ahmed; Jeremy Anuntiyo; Charles J Malemud; Tariq M Haqqi
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.